Return to drugs

Miropentan

Капсулы By prescription

Miropentan is a prescription medicine used to treat bladder pain or discomfort associated with interstitial cystitis

Miropentan

Important

The efficacy/safety of sodium polysulfate pentosan should be evaluated at least every 6 months. If improvement is not achieved 6 months after the start of treatment, sodium pentosan polysulfate treatment should be discontinued. Treatment with sodium polysulfate pentosan should be continued as long as the response persists. Visit the portal about Interstitial Cystitis https://icystit.ru

Indications

Control of pain or bladder discomfort associated with interstitial cystitis

Contraindications

Hypersensitivity to sodium pentosan polysulfate or any excipient of the drug, age under 18 years.


Increased risk of bleeding (including that caused by therapy with anticoagulants of coumarin group, heparin, tissue plasminogen activator t-PA, streptokinase, high doses of acetylsalicylic acid or other non-steroidal anti-inflammatory drugs), haemophilia.

Caution

Miropentan should be used with caution in patients with hepatic dysfunction, in patients with aneurysm, thrombocytopenia, gastrointestinal ulcer disease, polyps, diverticulum formation, during pregnancy and breastfeeding.

Bladder pain syndrome is a diagnosis of exclusion, other urological disorders (such as urinary tract infection or bladder cancer) must be excluded before treatment.

Usage

It is recommended to take Miropentan orally, drinking sufficient water, 1 hour before or 2 hours after a meal.
The recommended dose of sodium polysulfate pentosan is 300 mg per day - 1 capsule (100 mg each) 3 times a day.

Download full instruction

Report undesirable reaction

If you have information about undesirable reaction after taking the drug

Hotline +7 (495) 984-28-47

Report

Where to buy

Buy in online pharmacy

Have questions? Contact Us

Drugs in the category Urology

Has contraindications. Needs specialist overview.

Please read our privacy policy

The present personal data processing policy is drawn up in accordance with the requirements of the Federal Law of July 27, 2006. No. 152-FЗ “On Personal Data” and determines the procedure for processing personal data and measures to ensure the security of personal data of Mir-Pharm LLC (hereinafter referred to as the Operator).

The operator sets as his most important goal and condition for the implementation of his activities the respect for the rights and freedoms of man and citizen in the processing of his personal data, including the protection of the rights to privacy, personal and family confidentiality.

The Operator's policy regarding the processing of personal data (hereinafter - the Policy) applies to all information that the Operator can receive about visitors of the website https://mirpharm.ru.

The user can get any clarification on issues of interest regarding the processing of his personal data by contacting the Operator via e-mail info@mirpharm.ru.

The current version of the Policy is located in free access on the Internet at https://mirpharm.ru/policy.

This document will reflect any changes in the policy of processing personal data by the Operator. The policy is valid indefinitely until it is replaced with a new version.

Read more